Biognosys


Biognosys is a leading provider of next-generation proteomics solutions, supporting pharma and biotech research and clinical development. They focus on high-resolution mass spectrometry for protein quantification, offering services, software, and kits to enable discovery, validation, and clinical research in proteomics. Their mission is to transform life science through innovative proteomics technology and data analytics, making insights accessible for advancing healthcare and personalized medicine.

Industries

biotechnology
clinical-trials
communities
genetics
health-care

Nr. of Employees

medium (51-250)

Biognosys


Patents

Data independent acquisition of product ion spectra and reference spectra library matching

US-12033839-B2

View Details

Labelled compounds and methods for mass spectrometry-based quantification

US-11754571-B2

View Details

Labelled compounds and methods for mass spectrometry-based quantification

US-11293928-B2

View Details

Data independent acquisition of product ion spectra and reference spectra library matching

US-11222775-B2

View Details

Methods and systems for experimental set-up and data analysis in targeted proteomics applications

US-9435778-B2

View Details

Data independent acquisition of product ion spectra and reference spectra library matching

US-9343279-B2

View Details
View All Patents

Products

DIA proteomics analysis software (desktop and cloud/HPC)

Software for analysis of DIA proteomics data, supporting spectral library generation, targeted extraction and scalable processing in desktop, cloud or HPC environments.

DDA proteomics data analysis software with integrated search engine

Software solution for DDA data processing with support for isobaric labeling quantification and an integrated search engine.

Targeted proteomics assay design and analysis software

Software to design and analyze targeted MS assays and to optimize panel performance for high-throughput targeted quantification.

QC and facility performance monitoring software

Quality control tools for monitoring mass-spectrometry facility performance, integrating retention-time indexing and QC peptide standards.

Stable isotope-labeled reference peptide kit for plasma quantification

Defined sets of stable isotope-labeled peptides for standardized plasma proteomics quantification to enable reproducible measurements across studies.

Retention-time indexing and QC peptide kits

Retention time indexing standards and QC peptide sets for alignment and performance monitoring of LC-MS runs.

View All Products

Services

Unbiased proteome discovery services for plasma, biofluids and tissue to identify biomarker candidates and biological mechanisms using high-depth MS workflows.

Targeted assay development and absolute quantification using stable isotope-labeled standards for pharmacodynamic and clinical biomarker panels.

Proteomics and structural proteomics pipelines to identify compound targets, characterize mechanism of action, and validate target engagement.

Discovery and targeted phosphoproteomics workflows to map signaling changes, identify modified sites, and enable pathway-level interpretation.

Mass spectrometry services to profile peptides presented by MHC molecules for antigen discovery and immune-monitoring applications.

High-plex affinity-based panel services for targeted biomarker measurement in inflammation, CNS and other indication-specific panels.

View All Services

Expertise Areas

  • Large-scale discovery proteomics using DIA
  • Plasma and tissue biomarker discovery
  • Targeted quantitative proteomics and absolute quantification
  • Phosphoproteomics and signaling analysis
  • Show More (11)

Key Technologies

  • Data-independent acquisition (DIA) mass spectrometry
  • Data-dependent acquisition (DDA) mass spectrometry
  • Ion mobility-enabled mass spectrometry
  • Spectral library generation and targeted extraction
  • Show More (10)

News & Updates

Highlighting the diverse applications supported by Biognosys' software in 2024.

IonOpticks’ chromatography column becomes Biognosys’ standard for high-quality proteomic insights.

Biognosys presents innovations across proteomics research applications at HUPO Congress.

Biognosys enters reselling agreement for Spectronaut proteomics software with a leading provider.

Biognosys announces commercial availability of NULISA™ proteomics assay services for biomarker research.

Overview of Spectronaut® 19 features for large-scale proteomics analysis.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.